Status:

RECRUITING

EndoPAT Device for Endothelial Dysfunction in ED

Lead Sponsor:

University of California, Irvine

Conditions:

Erectile Dysfunction

Hypogonadism, Male

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6...

Detailed Description

Endothelial Dysfunction and Cardiovascular Health: Endothelial dysfunction is characterized by impaired endothelium-dependent vasodilation, which is a critical factor in the development and progressio...

Eligibility Criteria

Inclusion Criteria:

  • Males 18 years old and above
  • Diagnosed with erectile dysfunction or hypogonadism

Exclusion Criteria:

  • Patients without the above criteria

Key Trial Info

Start Date :

August 13 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06720597

Start Date

August 13 2025

End Date

January 1 2027

Last Update

February 2 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCI Urology | Men's Health Center

Newport Beach, California, United States, 92660

EndoPAT Device for Endothelial Dysfunction in ED | DecenTrialz